Search Results - "Brunner–Ferber, Françoise"

Refine Results
  1. 1

    Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial by van Delden, Christian, Köhler, Thilo, Brunner-Ferber, Françoise, François, Bruno, Carlet, Jean, Pechère, Jean-Claude

    Published in Intensive care medicine (01-07-2012)
    “…Purpose Anti-virulence strategies have not been evaluated for the prevention of bacterial infections. Prolonged colonization of intubated patients with…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Biases affecting injected doses of an experimental drug during clinical trials by Perrottet, Nancy, Brunner-Ferber, Françoise, Grouzmann, Eric, Spertini, François, Biollaz, Jérôme, Buclin, Thierry, Widmer, Nicolas

    “…During clinical trials, researchers rarely question nominal doses specified on labels of investigational products, overlooking the potential for inaccuracies…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans by Pentikainen, P J, Saraheimo, M, Schwartz, J I, Amin, R D, Schwartz, M S, Brunner-Ferber, F, Rogers, J D

    Published in Journal of clinical pharmacology (01-02-1992)
    “…Twelve healthy male volunteers received single market-image 40-mg oral doses of lovastatin and simvastatin (both lactone prodrugs), or pravastatin (a…”
    Get more information
    Journal Article
  8. 8

    Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men by Kleinbloesem, C H, Jaquet-Müller, F, al-Hamdan, Y, Baldauf, C, Gisclon, L, Wesnes, K, Curtin, C R, Stubbs, R J, Walker, S A, Brunner-Ferber, F

    Published in Clinical pharmacology and therapeutics (01-06-1996)
    “…Mazapertine is a structurally novel antipsychotic compound with high affinity for D2, D3, 5-HT1a, and alpha 1 receptors. The objectives were to determine…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Assessment of systemic effects of different ophthalmic beta-blockers in healthy volunteers by Bauer, K, Brunner-Ferber, F, Distlerath, L M, Lippa, E A, Binkowitz, B, Till, P, Kaik, G

    Published in Clinical pharmacology and therapeutics (01-06-1991)
    “…Systemic beta-blockade after single doses of ophthalmic beta-blockers (one drop in each eye) was investigated in healthy volunteers in two randomized,…”
    Get more information
    Journal Article
  11. 11

    Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjects by Buclin, T, Biollaz, J, Lippa, E A, Brunner-Ferber, F, van Melle, G, Munafo, A, Clineschmidt, C, Schelling, J L

    Published in Clinical pharmacology and therapeutics (01-06-1991)
    “…Potential systemic effects of the racemic carbonic anhydrase inhibitor MK-927 and its S-enantiomer, sezolamide hydrochloride, after topical ocular…”
    Get more information
    Journal Article
  12. 12

    Sezolamide: Additivity to timolol twice daily by GUNNING, F, BECHETOILLE, A, GREVE, E, LIPPA, E. A, PFEIFFER, N, GERLING, J, HOLDER, D, CLINESCHMIDT, C, BUNTINX, A, BRUNNER-FERBER, F. L, GREHN, F

    Published in Eye (London) (01-01-1992)
    “…Sezolamide, a potent topical carbonic anhydrase inhibitor previously known as MK-417, was studied to determine its ocular hypotensive activity in patients with…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitor by Lippa, E A, von Denffer, H A, Hofmann, H M, Brunner-Ferber, F L

    Published in Archives of ophthalmology (1960) (01-12-1988)
    “…A three-dose, randomized, double-masked, parallel, placebo-controlled ocular tolerance study was undertaken in 12 healthy, normal volunteers with the…”
    Get more information
    Journal Article
  15. 15

    Multiple-dose efficacy comparison of the two topical carbonic anhydrase inhibitors sezolamide and MK-927 by Bron, A, Lippa, E A, Gunning, F, Bénichou, C, Lesure, P, Sirbat, D, Royer, J, Flament, J, Clineschmidt, C, Panebianco, D

    Published in Archives of ophthalmology (1960) (01-01-1991)
    “…The multiple-dose twice-daily efficacy of the topical carbonic anhydrase inhibitor MK-927, a racemic compound, was compared with that of its pharmacologically…”
    Get more information
    Journal Article
  16. 16

    Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100 240, on endocrine and renal functions in healthy volunteers by Rousso, Philippe, Buclin, Thierry, Nussberger, Jürg, Décosterd, Laurent A, La Roche, Salome D, Brunner-Ferber, Françoise, Brunner, Hans R, Biollaz, Jérôme

    Published in Journal of hypertension (01-03-1999)
    “…OBJECTIVETo investigate the endocrine and renal effects of the dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100 240. DESIGNA…”
    Get full text
    Journal Article
  17. 17

    MK-927: a topically effective carbonic anhydrase inhibitor in patients by Bron, A M, Lippa, E A, Hofmann, H M, Feicht, B I, Royer, J G, Brunner-Ferber, F L, Panebianco, D L, Von Denffer, H A

    Published in Archives of ophthalmology (1960) (01-08-1989)
    “…The effects on intraocular pressure of the novel topical carbonic anhydrase inhibitor MK-927 were investigated for the first time in patients. Three drops of…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Site of the action of a synthetic atrial natriuretic peptide evaluated in humans by Biollaz, Jérôme, Bidiville, Jacques, Diézi, Jacques, Waeber, Bernard, Nussberger, Jürg, BrunnerFerber, Françoise, Gomez, Hector J., Brunner, Hans R.

    Published in Kidney international (01-10-1987)
    “…Site of the action of a synthetic atrial natriuretic peptide evaluated in humans. The renal site of the natriuretic effect of human, atrial natriuretic peptide…”
    Get full text
    Journal Article
  20. 20

    Activities of Human Acidic Fibroblast Growth Factor in an In Vitro Dermal Equivalent Model by Dubertret, Louis, Brunner-Ferber, Françoise, Misiti, John, Thomas, Kenneth A., Dubertret, Marie-Liesse

    Published in Journal of investigative dermatology (01-11-1991)
    “…Acidic fibroblast growth factor is a potent mitogen for human dermal fibroblasts in an in vitro three-dimensional collagen matrix, the “dermal equivalent.”…”
    Get full text
    Journal Article